Dr.Max has moved from the 4th to the 3rd place of biggest pharmacy chains according to the number of pharmacies in Europe. The number of pharmacies is reaching 2300 in 6 countries where we are operating. The goal is to keep growing further, not only in number of pharmacies, but also in the quality of highly professional service we provide to our customers, both offline and online.
Dr. Max Becomes 3rd Largest Group in Europe in Number of Pharmacies
“I’m enthusiastic to share a remarkable result as part of an extremely dynamic economic environment. I’m proud that Dr.Max achieved the 3rd position in Europe in terms of number of healthcare retail pharmacies owned. This achievement has been possible thanks to the biggest asset we can have in our business: the Team. We encourage our employees to grow within the company and establish themselves as the pillars on which the success of the company rests. I’m reflecting this statement with high optimism that this story is not at the end and many new things where we will see Dr.Max as the protagonist are ahead of us.”
Leonardo Ferrandino, President and Group CEO
Leonardo Ferrandino, President and Group CEO
Previous
Dr. Max Group is a European pharmaceutical concern owned by Penta, an investment group established in 1994, operating primarily in the countries of Central and Eastern Europe. Their offices are located in Prague, Bratislava, Warsaw, and Limassol. The business areas of Penta Investments include long-term investing in healthcare, financial services, retail, manufacturing, media and real estate development. The companies of Penta’s portfolio employ more than 43,000 people, with more than 15,000 professionals working in healthcare. The group’s assets value reached €14 billion in 2022.